These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. A three year follow up of preterm infants after moderately early treatment with dexamethasone. Romagnoli C; Zecca E; Luciano R; Torrioli G; Tortorolo G Arch Dis Child Fetal Neonatal Ed; 2002 Jul; 87(1):F55-8. PubMed ID: 12091294 [TBL] [Abstract][Full Text] [Related]
5. Delayed (>3 weeks) postnatal corticosteroids for chronic lung disease in preterm infants. Halliday HL; Ehrenkranz RA Cochrane Database Syst Rev; 2000; (2):CD001145. PubMed ID: 10796251 [TBL] [Abstract][Full Text] [Related]
6. Early postnatal (<96 hours) corticosteroids for preventing chronic lung disease in preterm infants. Halliday HL; Ehrenkranz RA Cochrane Database Syst Rev; 2000; (2):CD001146. PubMed ID: 10796252 [TBL] [Abstract][Full Text] [Related]
7. Moderately early (7-14 days) postnatal corticosteroids for preventing chronic lung disease in preterm infants. Halliday HL; Ehrenkranz RA Cochrane Database Syst Rev; 2000; (2):CD001144. PubMed ID: 10796416 [TBL] [Abstract][Full Text] [Related]
8. Effects of higher versus lower dexamethasone doses on pulmonary and neurodevelopmental sequelae in preterm infants at risk for chronic lung disease: a meta-analysis. Onland W; De Jaegere AP; Offringa M; van Kaam AH Pediatrics; 2008 Jul; 122(1):92-101. PubMed ID: 18595991 [TBL] [Abstract][Full Text] [Related]
10. Effect on growth of two different dexamethasone courses for preterm infants at risk of chronic lung disease. A randomized trial. Romagnoli C; Zecca E; Vento G; Maggio L; Papacci P; Tortorolo G Pharmacology; 1999 Nov; 59(5):266-74. PubMed ID: 10529659 [TBL] [Abstract][Full Text] [Related]
11. Effect of AAP statement regarding postnatal corticosteroids on ongoing and future randomized, controlled trials. Doyle L; Davis P; Morley C; Pediatrics; 2002 Nov; 110(5):1032-3; author reply 1032-3. PubMed ID: 12415053 [No Abstract] [Full Text] [Related]
12. Controlled trial of dexamethasone in neonatal chronic lung disease: an 8-year follow-up of cardiopulmonary function and growth. Mieskonen S; Eronen M; Malmberg LP; Turpeinen M; Kari MA; Hallman M Acta Paediatr; 2003 Aug; 92(8):896-904. PubMed ID: 12948063 [TBL] [Abstract][Full Text] [Related]
13. Postnatal corticosteroids in the treatment of chronic lung disease in the preterm infant: past, present, and future. Nye J Neonatal Netw; 2007; 26(5):293-9. PubMed ID: 17926659 [TBL] [Abstract][Full Text] [Related]
17. Effects of dexamethasone treatment on bone and collagen turnover in preterm infants with chronic lung disease. Crofton PM; Shrivastava A; Wade JC; Stephen R; Kelnar CJH ; Mcintosh N; Lyon AJ Pediatr Res; 2000 Aug; 48(2):155-62. PubMed ID: 10926289 [TBL] [Abstract][Full Text] [Related]
18. A randomized trial of two dexamethasone regimens to reduce side-effects in infants treated for chronic lung disease of prematurity. Odd DE; Armstrong DL; Teele RL; Kuschel CA; Harding JE J Paediatr Child Health; 2004; 40(5-6):282-9. PubMed ID: 15151582 [TBL] [Abstract][Full Text] [Related]
19. Current dilemmas in postnatal steroid therapy for chronic lung disease in preterm infants. Shinwell ES Biol Neonate; 2003; 84(1):96-100. PubMed ID: 12890944 [TBL] [Abstract][Full Text] [Related]
20. Postnatal steroids: a dilemma for the neonatologist. Halliday HL Acta Paediatr; 2001 Feb; 90(2):116-8. PubMed ID: 11236036 [No Abstract] [Full Text] [Related] [Next] [New Search]